Skip to content
Home/Companies/Biotech/QBio JRC

QBio JRC

Biotech·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns QBio JRC?

QBio JRC is a French Biotech company, currently owned by Elaia Partners since 2022.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Elaia Partners
Investor
Elaia Partners
Elaia Endowment Fund · 2020 · VC

Key facts

HQFrance
SectorBiotech

More from Elaia Endowment Fund

Other portfolio companies in the same fund.

Sensation Quantique
Sensation Quantique
Active
HealthTechFrance· 2022
Predilepsy
Predilepsy
Active
HealthTechFrance· 2021
Pyronear
Pyronear
Active
AI/MLFrance· 2021
Institut Analgesia
Institut Analgesia
Active
HealthTechFrance· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns QBio JRC?

QBio JRC is currently owned by Elaia Partners, through Elaia Endowment Fund, since 2022.

When did Elaia Partners acquire QBio JRC?

Elaia Partners acquired QBio JRC in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue